Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Pavlos Msaouel

Internal Medicine
MD Anderson
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
MD Anderson
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Pavlos Msaouel is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Msaouel is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Neuroendocrine Tumor, Nephrectomy, and Gamma Knife Radiosurgery.

His clinical research consists of co-authoring 217 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

MD Anderson
2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, Houston, TX 77030
Call: 713-592-5433

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

A Multicenter, Open-label Rollover Study of Sitravatinib Alone or in Combination With Other Anticancer Therapies in Patients With Advanced or Metastatic Solid Malignancies
A Multicenter, Open-label Rollover Study of Sitravatinib Alone or in Combination With Other Anticancer Therapies in Patients With Advanced or Metastatic Solid Malignancies
Enrollment Status: Completed
Publish Date: October 10, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Phase II Trial of Ixazomib Combined With Gemcitabine and Doxorubicin in Patients With Renal Medullary Carcinoma
Phase II Trial of Ixazomib Combined With Gemcitabine and Doxorubicin in Patients With Renal Medullary Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2025
Intervention Type: Drug
Study Drugs: Doxorubicin, Doxorubicin Hydrochloride, Gemcitabine, Gemcitabine Hydrochloride, Ixazomib, Ixazomib Citrate
Study Phase: Phase 2
Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2025
Intervention Type: Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase II Trial of Sitravatinib Plus Nivolumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma Who Progressed on Prior Treatment Acronym: SNAPI (Sitravatinib and Nivolumab After Prior Immunotherapy)
A Phase II Trial of Sitravatinib Plus Nivolumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma Who Progressed on Prior Treatment Acronym: SNAPI (Sitravatinib and Nivolumab After Prior Immunotherapy)
Enrollment Status: Active_not_recruiting
Publish Date: June 04, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Nivolumab, Sitravatinib
Study Phase: Phase 2
Phase I/II Trial of MGCD516 Combined With Nivolumab in Patients With Advanced Clear Cell Renal Cell Cancer That Progressed on Prior VEGF-Targeted Therapy
Phase I/II Trial of MGCD516 Combined With Nivolumab in Patients With Advanced Clear Cell Renal Cell Cancer That Progressed on Prior VEGF-Targeted Therapy
Enrollment Status: Completed
Publish Date: November 19, 2024
Intervention Type: Other, Drug, Biological
Study Drugs: Nivolumab, Sitravatinib
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

217 Total Publications

Interpreting statistical evidence with S values.
Interpreting statistical evidence with S values.
Journal: Anaesthesia
Published: August 18, 2025
View All 217 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jennifer Wang
Internal Medicine
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jennifer Wang
Internal Medicine
1515 Holcombe Blvd, 
Houston, TX 
 (0.6 miles away)
713-792-2830
Languages Spoken:
English
See accepted insurances

Jennifer Wang is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Upper Tract Urothelial Carcinoma (UTUC), and Muscle Invasive Bladder Cancer.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Kelvin M. Lee
Internal Medicine
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Kelvin M. Lee
Internal Medicine
6565 Fannin St, 
Houston, TX 
 (0.5 miles away)
713-790-3311
Languages Spoken:
English
See accepted insurances

Kelvin Lee is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Liver Failure, Acute Kidney Failure, Chronic Inflammatory Demyelinating Polyneuropathy, Gastrostomy, and Endoscopy.

Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Andrew W. Hahn
Internal Medicine
Experienced in WT1-Related Wilms Tumor Syndromes
Dr. Andrew W. Hahn
Internal Medicine

MD Anderson

1515 Holcombe Blvd, 
Houston, TX 
 (0.6 miles away)
713-792-2121
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Hahn is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Hahn is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Glycogen Storage Disease Type 6, Chromophobe Renal Cell Carcinoma, Obesity, and Prostatectomy.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Msaouel's expertise for a condition
ConditionClose
  • Elite
  • Renal Cell Carcinoma (RCC)
    Dr. Msaouel is
    Elite
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Distinguished
  • Chromophobe Renal Cell Carcinoma
    Dr. Msaouel is
    Distinguished
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Msaouel is
    Distinguished
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Familial Wilms Tumor 2
    Dr. Msaouel is
    Distinguished
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Neuroendocrine Tumor
    Dr. Msaouel is
    Distinguished
    . Learn about Neuroendocrine Tumor.
    See more Neuroendocrine Tumor experts
  • Wilms Tumor
    Dr. Msaouel is
    Distinguished
    . Learn about Wilms Tumor.
    See more Wilms Tumor experts
  • WT1-Related Wilms Tumor Syndromes
    Dr. Msaouel is
    Distinguished
    . Learn about WT1-Related Wilms Tumor Syndromes.
    See more WT1-Related Wilms Tumor Syndromes experts
  • Advanced
  • Cerebral Hypoxia
    Dr. Msaouel is
    Advanced
    . Learn about Cerebral Hypoxia.
    See more Cerebral Hypoxia experts
  • Muscle Invasive Bladder Cancer
    Dr. Msaouel is
    Advanced
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Nephrectomy
    Dr. Msaouel is
    Advanced
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Experienced
  • Agranulocytosis
    Dr. Msaouel is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anemia
    Dr. Msaouel is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
  • Atrial Septal Defect (ASD)
    Dr. Msaouel is
    Experienced
    . Learn about Atrial Septal Defect (ASD).
    See more Atrial Septal Defect (ASD) experts
  • Breast Cancer
    Dr. Msaouel is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Choriocarcinoma
    Dr. Msaouel is
    Experienced
    . Learn about Choriocarcinoma.
    See more Choriocarcinoma experts
  • Colitis
    Dr. Msaouel is
    Experienced
    . Learn about Colitis.
    See more Colitis experts
View All 26 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved